Showing 1 - 8 results of 8 for search 'Francesco Ravera', query time: 0.04s Refine Results
  1. 1
    Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications

    Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications by Gabriella Cirmena, Martina Dameri, Francesco Ravera, Piero Fregatti, Alberto Ballestrero, Gabriele Zoppoli

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer

    Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer by Mohamed Omar, Pier Vitale Nuzzo, Francesco Ravera, Sara Bleve, Giuseppe Nicolò Fanelli, Claudio Zanettini, Itzel Valencia, Luigi Marchionni

    Published 2023-11-01
    Get full text
    Article
  3. 3
    The Inflammatory Cytokine IL-3 Hampers Cardioprotection Mediated by Endothelial Cell-Derived Extracellular Vesicles Possibly via Their Protein Cargo

    The Inflammatory Cytokine IL-3 Hampers Cardioprotection Mediated by Endothelial Cell-Derived Extracellular Vesicles Possibly via Their Protein Cargo by Claudia Penna, Saveria Femminò, Marta Tapparo, Tatiana Lopatina, Kari Espolin Fladmark, Francesco Ravera, Stefano Comità, Giuseppe Alloatti, Ilaria Giusti, Vincenza Dolo, Giovanni Camussi, Pasquale Pagliaro, Maria Felice Brizzi

    Published 2020-12-01
    Get full text
    Article
  4. 4
    Motor Deficits and Cerebellar Atrophy in Elovl5 Knock Out Mice

    Motor Deficits and Cerebellar Atrophy in Elovl5 Knock Out Mice by Eriola Hoxha, Eriola Hoxha, Rebecca M. C. Gabriele, Ilaria Balbo, Francesco Ravera, Linda Masante, Vanessa Zambelli, Cristian Albergo, Nico Mitro, Donatella Caruso, Eleonora Di Gregorio, Alfredo Brusco, Barbara Borroni, Filippo Tempia, Filippo Tempia, Filippo Tempia

    Published 2017-10-01
    Get full text
    Article
  5. 5
    Percutaneous Coronary Intervention (PCI) Reprograms Circulating Extracellular Vesicles from ACS Patients Impairing Their Cardio-Protective Properties

    Percutaneous Coronary Intervention (PCI) Reprograms Circulating Extracellular Vesicles from ACS Patients Impairing Their Cardio-Protective Properties by Saveria Femminò, Fabrizio D’Ascenzo, Francesco Ravera, Stefano Comità, Filippo Angelini, Andrea Caccioppo, Luca Franchin, Alberto Grosso, Cecilia Thairi, Emilio Venturelli, Claudia Cavallari, Claudia Penna, Gaetano Maria De Ferrari, Giovanni Camussi, Pasquale Pagliaro, Maria Felice Brizzi

    Published 2021-09-01
    Get full text
    Article
  6. 6
    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).

    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). by Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study

    Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study by Francesco Ravera, Roberto Borea, Gabriella Cirmena, Martina Dameri, Lorenzo Ferrando, Maurizio Gallo, Cecilia Casini, Neri Fallani, Mario Stabile, Valentina Barbero, Roberto Murialdo, Lucia Tixi, Margherita Cappuccio, Andrea Cuboni, Irene Sivieri, Giuseppe Fornarini, Andrea De Maria, Alberto Ballestrero, Gabriele Zoppoli

    Published 2022-05-01
    Get full text
    Article
  8. 8
    Clinical outcomes of volume of disease on patients receiving enzalutamide abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

    Clinical outcomes of volume of disease on patients receiving enzalutamide abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate ca... by Pier Vitale Nuzzo, Francesco Ravera, Calogero Saieva, Elisa Zanardi, Giuseppe Fotia, Andrea Malgeri, Sabrina Rossetti, Loana Bueno Valença, Talal El Zarif, Matthew P. Davidsohn, Heather McClure, Thiago Martins Oliveira, Charles Vauchier, Ricardo Pereira Mestre, Mikol Modesti, Praful Ravi, Anna Patrikidou, Sandro Pignata, Giuseppe Procopio, Giuseppe Fornarini, Ugo De Giorgi, Antonio Russo, Edoardo Francini

    Published 2023-03-01
    Get full text
    Article

Search Tools: